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Abstract
Background: Metabolic syndrome is a growing public health problem worldwide. Several interventions have been
proposed to specifically target the problem. This study evaluated the effectiveness of an interactive web-based
lifestyle for management of metabolic syndrome.
Methods: This randomized controlled trial was conducted from June through August 2012 in Tehran, Iran.
Participants were individuals with metabolic syndrome who had registered on the study website. Interested
eligible participants were invited for a free clinic visit and clinical assessment. They were randomly assigned to the
intervention (n = 80) or control (n = 80) group. The intervention group received an interactive web-based program
called the Healthy Heart Profile and were followed for 6 months. The control group received general information
on metabolic syndrome. Anthropometric measures, glycemic status, and lipid profile were evaluated at baseline,
and at 3- and 6-month follow-up assessments. Metabolic syndrome was defined according to The National
Cholesterol Education Program Adult Treatment Panel (ATP) III report except for waist circumference, which was
modified to ≥90 cm for both genders for the Iranian population.
Results: In total, 1,437 individuals registered on the study website. The mean age of participants was 44.2 years
(SD = 10.0). There were no significant differences between the intervention and control groups on any baseline
variable except that participants in the intervention group recorded higher levels of LDL. The results showed a
decrease in metabolic syndrome in both groups. These reductions were significantly greater in the intervention
group at the 3- and 6-month follow-ups. The intervention group showed significantly greater decreases (P < 0.05)
over the control group for, respectively, systolic blood pressure (3-month: −10 versus −6 mmHg; 6-month: −11
versus −8 mmHg), diastolic blood pressure (3-month: −10 versus −4 mmHg; 6-month: −11 versus −6 mmHg),
weight (3-month: −2 versus −1 kg; 6-month: −4 versus −1 kg), body mass index (3-month: −0.5 versus −0.2 kg/m2;
6-month: −1.1 versus −0.4 kg/m2) and improvement in HDL (3-month: 2 versus 0.64 mg/dl; 6-month: 6 versus
4 mg/dl).
Conclusion: The findings suggest that the web-based interactive program was beneficial for individuals with
metabolic syndrome. Comprehensive interactive web-based prevention programs are promising to help involve
patients in improving management of metabolic syndrome and adopting a healthy lifestyle.
Trial registration: IRCT201111198132N1. Registered 27 May 2013.
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Background
Metabolic syndrome is a growing public health problem
worldwide. In Iran, it affects approximately 25 % of the
population and has become a leading health concern be-
cause of its link to cardiovascular disease [1, 2]. Meta-
bolic syndrome is identified by central obesity, increased
triglycerides, reduced high-density lipoprotein choles-
terol (HDL), hypertension, and elevated fasting blood
glucose level [3]. The National Cholesterol Education
Program Adult Treatment Panel (ATP) III defines
metabolic syndrome as the presence of three or more of
the following conditions: triglyceride level of at least
150 mg/dl, HDL of < 40 mg/dl in men and < 50 mg/dl in
women, systolic/diastolic blood pressure (BP) of ≥ 130/
85 mm Hg, fasting blood glucose (FBG) level of ≥110 mg/dl,
and waist circumference > 102 cm in men and > 88 cm in
women [4]. The current definitions of central adiposity
are based on data from western populations; however, a
growing body of literature indicates that this cut-off likely
needs to be lowered for Asian populations. Several studies
in Iran have suggested that a more realistic waist circum-
ference for Iranians is > 90 cm for both genders [5–7].
ATP III states that a change in lifestyle is the essential
strategy for control and management for individuals at
risk of cardiovascular disease [8].
Evidence shows that lifestyle intervention programs
play a crucial role in the control and treatment of meta-
bolic syndrome. Changing dietary habits and exercise
behavior can bring about a healthier waistline measure-
ment and body mass index (BMI), improve HDL and tri-
glyceride levels, and lower BP and blood glucose levels
[9]. A recent meta-analysis of results from clinical stud-
ies on lifestyle modification and metabolic syndrome
showed that the proportion of people with resolved
metabolic syndrome in the intervention group was ap-
proximately twofold that of the control group. The re-
port also showed that five out of six components of
metabolic syndrome decreased significantly in the inter-
vention groups compared to the control groups [10].
Although traditional face-to-face lifestyle intervention is
the gold standard for modification of lifestyle and counsel-
ing for healthy behavior [11, 12], it faces obstacles such as
availability, cost, treatment, time, travel demands, and lim-
ited effectiveness [13]. Web-based lifestyle programs can
reduce these obstacles while maintaining effectiveness by
offering a feasible strategy to improve health status for
large numbers of at-risk people either as a stand-alone
approach or as a supplement to face-to-face encounters
[11, 12]. The Internet plays an increasingly important role
in health care by providing a platform for large-scale deliv-
ery of information and interventions for modifying life-
style risk factors [14].
Several review studies have explored the effectiveness
of web-based and e-health intervention to improve
outcomes for lifestyle modification, weight management,
physical activity, and dietary intake with equivocal re-
sults [15–18]. The use of interactive web-based pro-
grams could increase the effectiveness of intervention;
however, the effects of web-based interactive lifestyle
modifications for people with metabolic syndrome re-
main unclear. The present randomized controlled trial
evaluated the effectiveness of interactive web-based life-
style intervention for metabolic syndrome. It was hy-
pothesized that an interactive web-based educational
program will promote changes in lifestyle behaviors that
in turn will result in a decrease in metabolic syndrome.
Methods
Design overview
The Red Ruby was a randomized controlled trial con-
ducted in Tehran, Iran. A detailed description of the
method can be found elsewhere in a presentation of the
study protocol [19]. Briefly, this study was designed to
assess the effects of interactive web-based lifestyle inter-
vention on metabolic syndrome. The main outcomes
were a decrease in the components of metabolic syn-
drome. The study was concluded at the 6-month follow-
up because the results indicated early effectiveness of
lifestyle intervention on changing the components of
metabolic syndrome [20, 21].
Participants and inclusion criteria
A total of 160 people diagnosed with metabolic syn-
drome were randomly assigned to an intervention or
control group. Participants who had registered on the
study website (http://www.Heartresearch.ir) from June
through August 2012 were recruited. These were indi-
viduals with metabolic syndrome aged 20 years and over
living in Tehran and registered on the study website.
The inclusion criteria were: waist circumference ≥ 90
(cut-off for metabolic syndrome in Iran for both genders
[5–7]) and BP ≥ 130/85 plus one or more metabolic syn-
drome components, and having access to and the basic
skills necessary to use the Internet. Exclusion criteria
were having a history of cardiovascular disease, diabetes,
cancer, or renal disease, being pregnant, taking me-
dication for hypertension or dyslipidemia, or failing to
complete the registration form. Participants were as-
sessed at baseline and at 3- and 6-month follow-ups.
Procedures
The study procedure from enrollment to data collection
and followup assessment are present in Additiinal file 1.
Announcements for recruitment were placed on virtual
and non-virtual environments at the Tehran Heart Cen-
ter, Tehran University of Medical Sciences, and Iranian
Student News Agency. These announcements offered the
opportunity to take part in a free online preventive
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intervention for cardiovascular disease with the aim of
promoting lifestyle behavior including a healthful diet and
physical activity. Those interested in participating were in-
vited to register and complete an online form.
The registration page included the name, gender, age,
waist circumference, weight, e-mail, and address of the
applicant. The homepage also explained how to measure
waist circumference. The website database was reviewed
by a trained research assistant to recognize registrants
aged 20 and over living in Tehran (the study setting).
The participants who initially enrolled were contacted
by telephone for eligibility screening. During the phone
interview eligible participants who were interested in
participating in the study were asked to schedule a free
clinic visit and clinical assessment by trained nursing
staff at Tehran Heart Center.
Randomization
The enrolled participants completed all baseline assess-
ments and were allocated to either the intervention or
control group. The allocation sequence was concealed
from the main investigator (LJ) in sequentially numbered,
opaque, sealed and stapled envelopes. The randomization
sequence was created manually by a biostatistician using
Excel software to assign participants to the study arms
using a 1:1 allocation ratio with a block size of 4. Due to
the nature of the study (waiting-list controlled), it was not
possible to blind participants to intervention allocation.
Intervention
Participants in both the intervention and control groups
were informed of their metabolic syndrome and its com-
ponents by e-mail and encouraged to make appropriate
changes to their dietary intake and physical activity to
manage their syndrome. The participants in the inter-
vention group received the username and password for
log-in to a personal homepage and were encouraged to
regularly visit their own profile.
My Healthy Heart Profile
My Healthy Heart Profile is a free Internet-based pro-
gram with key interactive features designed for preven-
tion of metabolic syndrome. My Healthy Heart Profile
was structured into five parts:
1. Educational materials: This page was updated with
new educational materials at least twice a month.
The educational material included methods to
lower cholesterol and control high blood pressure,
conditions that put individuals at risk for
cardiovascular disease, the need to lose weight,
control of diabetes, the relationship between
physical activity and the heart, and information on
Dietary Approaches to Stop Hypertension (DASH).
E-mail reminders were sent to each participant each
time a new educational material was posted on the
website. All users received the same educational
materials. The e-mail reminders contained a brief
description of the educational materials and a
hyperlink to the website.
2. Personal information for name, age, gender, weight,
height, telephone number, and e-mail address.
3. Inbox: This was an interactive section for
exchanging messages. A calorie-restricted diet tai-
lored by a dietitian was sent to each inbox.
This diet was based on each participant’s calorie
requirements according to his/her ideal body weight
(IBW) and corrected body weight (CBW) where less
than 30 % of the calories were derived from fat in
accordance with National Heart, Lung, and Blood
Institute guidelines [22]. The inbox provided an
opportunity for ongoing discussion between the user
and the dietitian. The users could only communicate
with the dietitian through this part of the website.
Users could post their answers at any time they
wished and would receive a response within
24 hours.
4. Estimation of Framingham Stroke Risk (FSR) is an
interactive tool by which users can calculate
cardiovascular risk for 10 years based on the
Persian online version of the Framingham risk
score (by permission). The FSR considers the
cardiovascular risk factors of age (>20 years), gender
(male and female), total cholesterol (TC), HDL,
systolic BP, and smoking habits. Participants can
estimate their scores at every log-in and obtain
feedback by text for the three traffic signals used to
illustrate the three levels of risk (high, moderate, low).
5. Anthropometric and clinical measures recorded
periodic measurements of user weight, waist
circumference, BMI, BP, TC, LDL, HDL,
triglycerides, and FBG. A simple graph displayed the
measurements in one of the three warning colors
(red = needs attention, orange = close to risk,
green = good) for each record.
Control
Participants in the control group were kept on a waiting
list and received e-mail messages every three weeks that
included information about metabolic syndrome and
general information about healthy nutrition and the ben-
efits of fruit and vegetable intake, physical activity, and
lowering body weight.
Outcome measures
The primary outcomes were a change in waist cir-
cumference, weight, systolic and diastolic BP, HDL, TC,
triglycerides, LDL, and FBG. Metabolic syndrome was
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defined according to The National Cholesterol Education
Program ATP III as the presence of three or more of the
following conditions (except for waist circumference,
which was set at ≥ 90 cm for both genders for
Iranians): triglycerides < 150 mg/dl, HDL < 40 mg/dl
for men and < 50 mg/dl for women, BP < 130/85 mm
Hg, and fasting blood glucose (FBG) < 110 mg/dl.
Waist circumference was evaluated using a measuring
tape to the nearest 0.1 cm. The weight of an individual
dressed in light clothing without shoes was recorded
each time using a calibrated scale (Seca; model
8811021658; Germany) to the nearest 0.1 kg. Height
was measured without shoes using a stadiometer (Seca;
Germany) to the nearest 0.1 cm. BP was measured with
a mercury sphygmomanometer twice in the same
arm after the individual had been seated at rest for
10–15 min. The systolic and diastolic BP measurements
were the mean of the two readings. Blood sampling was
collected for measurement of TC, triglycerides, LDL,
HDL, and FBG for all participants. Overnight fasting for
12–14 hours was required before blood sampling. FBG
was measured using the glucose oxidase method (intra-
and inter-assay coefficients of variation of 2.1 % and 2.6 %,
respectively). BMI was measured by using the individual’s
weight in kilograms divided by the square of his/her
height in meters [23].
Sample size
The sample size was calculated based on a decrease in one
standard deviation (2.5 cm) in waist circumference [24] as
one of the most important components of metabolic syn-
drome [25]. A study with a power of 90 % at 5 % signifi-
cance level requires 60 participants in each arm. Giving
the risk of attrition risk, 80 participants per each group
were sought.
Statistical analysis
The data was presented as mean, standard deviation, and
percentage. Normal distribution of the data was assessed
using the Kolmogorov-Smirnov test and quantile-quantile
(Q-Q) plots. To compare baseline variables between two
groups, the t-test, Mann–Whitney U test, chi-square, and
Fisher exact tests were employed.
Any change in scores was calculated by subtracting the
baseline score from the 3- and 6-month follow-up scores.
Linear mixed model (LMM) analysis was used to evaluate
changes within groups. Adjustment for the multiple com-
parisons was done using the Bonferroni method. Time
points in the analyses included baseline, during interven-
tion (3-month follow-up), and at the termination of inter-
vention (6-month follow-up). Differences between groups
for each metabolic syndrome component and total compo-
nent scores were evaluated by intent-to-treat analysis using
LMM. All statistical analysis was performed by STATA
(version 11.0). Results were considered statistically signifi-
cant at P < 0.05.
Ethics
The ethics committee of Tehran University of Medical
Sciences, Vice Chancellor for Research approved the
study (number 90/130/1736). Written informed consent
was obtained from all participants. The CONSORT
checklist is provided in Additiinal file 2.
Results
Participants
In total, 1,437 individuals registered on the study website.
Of these, 815 records were excluded because registrants
were living outside Tehran (n = 356), had a waist circum-
ference < 90 cm (n = 392), or had incomplete information
(no telephone number; n = 67). The remaining 622 regis-
tered participants were screened for eligibility and 305
were excluded for the following morbid conditions: car-
diovascular disease (n = 68), diabetes (n = 51), consump-
tion of antihypertensive medication (n = 45), consumption
of cholesterol-lowering medication (n = 32), blood pres-
sure < 130/85 (mmHg) (n = 96), renal disease or cancer
(n = 12), or pregnancy (n = 1). A total of 317 individuals
were invited to participate. Of these, 229 were able to
attend clinical assessments and were scheduled for a
baseline visit. Of the attending participants for clinical
assessments, 171 met the criteria for inclusion and had
metabolic syndrome. Of these, 160 participants agreed
to complete the baseline measures and were randomly
assigned to intervention and control groups (see Add-
itional file 1).
The characteristics of the participants are presented in
Table 1. The mean age of participants was 44.2 years
(SD = 10.0) and ranged from 21 to 68 years. Participants
were predominantly male (66.3 %) and married (83.8 %).
Mean (SD) Internet usage was 13.2 hours per week
(SD = 15.5). The mean weight was 87 kg (SD = 15) and
BMI was 30.1 kg/m2 (SD = 4.6). There were no significant
differences between the intervention and control groups
on any baseline variable, except for LDL; participants in
the intervention group showed higher LDL values than
the control group.
The attrition rate in the intervention and control
groups at first follow-up was the same (20 %); however,
the control group had a significantly higher attrition rate
(33.7 %) compared to the intervention group (20 %) at
the 6-month follow-up. This information has been dis-
cussed elsewhere [26].
Changes in metabolic syndrome indicators
Table 2 shows the distribution of baseline and follow-up
values for changes in metabolic syndrome indicators
over time. The results of mixed model repeated
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measures analysis, including the interaction between
time and group, are shown. The interaction was signifi-
cant for weight, BMI, systolic and diastolic BP, and HDL
and indicated that the interactive web-based interven-
tion improved metabolic syndrome components.
Participants in both the intervention and control groups
had lost a significant amount of weight by the 6-month
follow-up. This was significantly greater in the interven-
tion group. At the 6-month follow-up, the intervention
group showed a significantly greater decrease (P < 0.001)
in systolic BP (3-month: −10 versus −6 mmHg and 6-
month: −11 versus −8 mmHg, respectively) and diastolic
BP (3-month: −10 versus −4 mmHg and 6-month: −6
versus −11 mmHg). Significant changes in HDL and BMI
(P < 0.05) were apparent in the intervention group during
follow-up. Within-group changes were observed in both
the intervention and control groups for weight, BMI, waist
circumference, BP, and TG during the follow-up assess-
ments. The within-group changes were significant in the
intervention group, but not in the control group.
The overall number of participants with metabolic
syndrome (showing at least three components) between
groups was also assessed. There were no significant dif-
ferences between groups for the number of metabolic
syndrome components at baseline, but generalized
LMM analysis (GLMM) at follow-up showed significant
differences between groups for the number of metabolic
syndrome components (P = 0.007; Fig. 1).
Table 1 Baseline characteristics of study participants
Total (n = 160) Control (n = 80) Intervention (n = 80) P
Age (mean, SD) 44 .5 ± 10 44.8 ± 10 43.3 ± 10.1 0.345a
Gender (number, %) 0.403c
Males 106 (66.3) 56 (70.0) 50 (62.5)
Females 54 (33.8) 24 (30.0) 30 (37.5)
Education (number, %) 0.080c
≤12 71 (44.4) 41 (51.3) 30 (37.5)
>12 89 (55.6) 39 (48.8) 50 (62.5)
Marital status (number, %) 0.113d
Single 21 (13.1) 14 (17.5) 7 (8.8)
Married 134 (83.8) 62 (77.5) 72 (90.0)
Divorced/widowed 5 (3.1) 4 (5.0) 1 (1.3)
Employment status (number, %) >0.99d
Employed 159 (99.4) 79 (98.8) 80 (100.0)
Unemployed 1 (0.6) 1 (1.3) 0 (0.0)
Smoking (number, %) 22 (13.8) 8 (10.0) 14 (17.5) 0.168c
Alcohol drinking (number, %) 9 (5.7) 5 (6.3) 4 (5.1) >0.99d
Drug addiction (number, %) 2 (1.3) 2 (2.5) 0 (0.0) 0.497d
Internet usage (hours/week) (mean, SD) 13.2 (15.5) 10.9 (13.7) 15.5 (16.9) 0.061
Weight (kg) (mean, SD) 87 ± 15 88 ± 14 87 ± 16 0.574a
Body mass index (kg/m2) (mean, SD) 30.1 ± 4.6 30.5 ± 4.5 29.8 ± 4.7 0.374a
Waist circumference (cm) (mean, SD) 104 ± 9 105 ± 9 103 ± 9 0.199a
Systolic blood pressure (mmHg) (mean, SD) 132 ± 11 132 ± 13 131 ± 8 0.593a
Diastolic blood pressure (mmHg) (mean, SD) 88 ± 6 88 ± 7 89 ± 6 0.594a
Total cholesterol (mg/dl) (mean, SD) 195 ± 39 191 ± 35 199 ± 44 0.181a
LDL cholesterol (mg/dl) (mean, SD) 129 ± 32 123 ± 31 134 ± 33 0.019a
HDL cholesterol (mg/dl) (mean, SD)
Women 39 ± 8 39 ± 10 39 ± 7 0.683b
Men 46 ± 11 48 ± 12 44 ± 10 0.086b
Triglycerides (mg/dl) (mean, SD) 192 ± 113 198 ± 127 186 ± 96 0.534b
Fasting blood glucose (mg/dl) (mean, SD) 90 ± 14 91 ± 15 89 ± 12 0.772b
Physical activity (met/mins.) (mean, SD) 493 ± 716 471 ± 750 515 ± 684 0.224b
aDerived from t-test. bDerived from Mann–Whitney test. cDerived from chi-square test. dDerived from Fisher exact test
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Table 2 Changes in cardiometabolic risk factors over time between groups
Time Control Intervention Time/group interactiona
mean (SD) mean (SD)
Weight (kg) Baseline Value 88 ± 14 87 ± 16 <0.001
3-month follow-up Value 86 ± 13 85 ± 14
Change −1 ± 3 −2 ± 2
Pb 0.059 <0.001
6-month follow-up Value 87 ± 12 83 ± 15
Change −1 ± 3 −4 ± 3
Pb <0.001 <0.001
Body mass index (kg/m2) Baseline Value 30.5 ± 4.5 29.8 ± 4.7 0.009
3-month follow-up Value 29.8 ± 3.8 29 ± 4
Change −0.2 ± 1 −0.5 ± 1
Pb 0.079 <0.001
6-month follow-up Value 29.5 ± 3.5 28.6 ± 4.4
Change −0.4 ± 1 −1.1 ± 1
Pb <0.001 <0.001
Waist circumference (cm) Baseline Value 105 ± 9 103 ± 9 0.64
3-month follow-up Value 103 ± 8 101 ± 8
Change −2 ± 4 −3 ± 3
Pb 0.385 <0.001
6-month follow-up Value 100 ± 18 99 ± 9
Change −5 ± 19 −4 ± 3
Pb 0.012 <0.001
Systolic blood pressure (mmHg) Baseline Value 132 ± 13 131 ± 8 0.016
3-month follow-up Value 127 ± 11 121 ± 13
Change −6 ± 14 −10 ± 11
Pb <0.001 <0.001
6-month follow-up Value 124 ± 8 120 ± 10
Change −8 ± 14 −11 ± 9
Pb <0.001 <0.001
Diastolic blood pressure (mmHg) Baseline Value 88 ± 7 89 ± 6 0.006
3-month follow-up Value 84 ± 9 80 ± 9
Change −4 ± 8 −10 ± 9
Pb <0.001 <0.001
6-month follow-up Value 82 ± 6 78 ± 6
Change −6 ± 7 −11 ± 6
pb <0.001 <0.001
Fasting blood glucose (mg/dl) Baseline Value 91 ± 15 89 ± 12 0.627
3-month follow-up Value 89 ± 13 85 ± 10
Change −1 ± 12 −4 ± 12
Pb 0.778 0.004
6-month follow-up Value 88 ± 13 85 ± 8
Change −2 ± 14 −4 ± 12
Pb 0.39 0.028
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Discussion
The findings from this web-based interactive random-
ized controlled trial showed that 6 months of lifestyle
intervention positively influenced several metabolic syn-
drome components. The number of participants with
metabolic syndrome decreased in both arms of the study;
however, a significantly greater decrease accompanied by
a lower attrition rate was observed for the intervention
group. The lifestyle intervention used was an interactive
education strategy that provided information and skills for
participants to assist them in achieving the recommended
physical activity levels and following a healthful diet plan.
Significant improvements were observed for weight loss,
reduced BMI, systolic, and diastolic BP, and increased HDL
at the 6-month follow-up. A similar study from Korea
showed that an 8-week Internet-based cardiovascular risk
reduction program resulted in significant changes in cardio-
vascular risk, waist circumference, diastolic blood pressure,
and fasting plasma glucose among male workers with meta-
bolic syndrome [27]. Although some studies detect no ef-
fect on cholesterol management [28], evidence from recent
studies support the current findings [29–31]. Bond et al.
[32] reported that a 6-month web-based intervention in
addition to usual simple care increased HDL-C, and de-
creased weight and HbA1C in patients with type 2 diabetes
mellitus. They reported that serum cholesterol and weight
decreased in both the intervention and control groups;
however, the decrease was greater in the intervention group
(P < 0.05), results which are consistent with the findings of
the present study.
Web-based interactive programs can motivate parti-
cipants to adhere better to clinical assessments and
Table 2 Changes in cardiometabolic risk factors over time between groups (Continued)
Total cholesterol (mg/dl) Baseline Value 191 ± 35 199 ± 44 0.25
3 months follow-up Value 188 ± 34 186 ± 37
Change −4 ± 29 −13 ± 45
Pb 0.409 0.019
6-month follow-up Value 186 ± 28 186 ± 34
Change −6 ± 24 −13 ± 41
Pb 0.591 0.049
Triglycerides (mg/dl) Baseline Value 198 ± 127 186 ± 96 0.606
3-month follow-up Value 175 ± 161 160 ± 84
Change −29 ± 132 −18 ± 85
Pb 0.075 0.04
6-month follow-up Value 144 ± 68 129 ± 54
Change −53 ± 82 −51 ± 77
Pb 0.029 <0.001
HDL (mg/dl) Baseline Value 42 ± 11 41 ± 8 0.018
0 ± 0 0 ± 0
3-month follow-up Value 42 ± 12 42 ± 9
Change 0.64 ± 11 2 ± 9
Pb 0.115 0.066
6-month follow-up Value 44 ± 11 46 ± 7
Change 4 ± 11 6 ± 8
Pb 0.066 <0.001
LDL Baseline Value 123 ± 31 134 ± 33 0.412
3-month follow-up Value 118 ± 29 126 ± 33
Change −6 ± 25 −6 ± 30
Pb 0.062 0.089
6-month follow-up Value 121 ± 22 126 ± 27
Change −3 ± 22 −7 ± 31
Pb 0.089 0.124
aBased on mixed model
bBased on mixed model, adjusted for the multiple comparisons by Bonferroni method
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desired behaviors for physical activity and a healthful
diet. Online health assessments provide valuable feed-
back and facilitate opportunistic intervention by includ-
ing assessment of multiple risk factors that provides a
comprehensive picture for patients and encourages them
to change lifestyle risk factors [31, 33].
One consistent finding on the topic is that the use of
multiple behavioral change techniques significantly in-
creased the effectiveness of a program [34–36]. The present
study showed that the use of an interactive website that is
frequently updated for informational content with e-mail
notifications, interactive risk assessment tools, and tracking
tools appeared to contribute to a change in lifestyle and
had a positive effect on metabolic syndrome components.
Assessing cardiovascular disease risk by using easy-to-use
online risk assessment tools could facilitate better decision-
making about lifestyle recommendations.
Risk factor assessment is the first step in primary pre-
vention and guides treatment strategy because the inten-
sity of the preventive recommendations is tailored to a
patient’s level of risk [37, 38]. The mode of delivery was
a key influencing factor when encouraging and persuad-
ing a participant to follow clinical assessments. Similar
studies have shown that sending tailored and timely
feedback, providing regular new and specific content
with periodic prompts, and sending reminders result in
better outcomes [39]. It appears that, in the current
study, following up of participants for clinical assess-
ment, sending the results of clinical assessments by e-
mail, and recording the assessments on their profiles
were additional factors to achieving successful results for
metabolic syndrome management.
One surprising finding was that, although women were
more likely to use the Internet to look for health infor-
mation than men, in line with previous studies [40–42],
men were more interested in the web-based programs
and participated more than women (66.3 % versus
33.8 %). This study highlights the importance of inter-
active web-based programs that have shown promise for
effective changes in lifestyle. However, in the battle
against the epidemic of metabolic syndrome, the primary
care settings are still the front lines [43].
Conclusions
This randomized controlled trial showed the potential
benefits of a web-based interactive program for individ-
uals with metabolic syndrome. The comprehensive inter-
active web-based prevention program was a promising
method of increasing the involvement of the participants
in improved management of metabolic syndrome and
adoption of a healthy lifestyle.
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